Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro
Year: 2016
Type: article
Abstract: Endothelin-1 (ET-1) autocrine and paracrine signaling modulate cell proliferation of tumor cells by activating its receptors, endothelin A receptor (ETAR) and endothelin B receptor (ETBR). Dysregulation of ETAR activation promotes tumor development and progression. The potential of ETAR antagonists and the dual-ETAR and ETBR antagonists as therapeutic approaches are under preclinical and clinical studies. Salvianolic acid A (Sal A) is a hydrophilic polyphenolic derivative isolated from Salvia miltiorrhiza Bunge (Danshen), which has been reported as an anti-cancer and cardio-protective herbal medicine. In this study, we demonstrate that Sal A inhibits ETAR activation induced by ET-1 in both recombinant and endogenous ETAR expression cell lines. The IC50 values were determined as 5.7 µM in the HEK293/ETAR cell line and 3.14 µM in HeLa cells, respectively. Furthermore, our results showed that Sal A suppressed cell proliferation and extended the doubling times of multiple cancer cells, including HeLa, DU145, H1975, and A549 cell lines. In addition, Sal A inhibited proliferation of DU145 cell lines stimulated by exogenous ET-1 treatment. Moreover, the cytotoxicity and cardio-toxicity of Sal A were assessed in human umbilical vein endothelial cells (HUVEC) and Human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which proved that Sal A demonstrates no cytotoxicity or cardiotoxicity. Collectively, our findings indicate that Sal A is a novel anti-cancer candidate through targeting ETAR.
DOI: 10.3390/ijms17081244
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: salvianolic acid A, ETA receptor, endothelin-1, endothelin receptor antagonists, Salvia miltiorrhiza, anticancer activity, tumor cell proliferation, cardiotoxicity, cytotoxicity, human induced pluripotent stem cell-derived cardiomyocytes, human umbilical vein endothelial cells, HeLa cells, lung cancer cells, prostate cancer cells
Open Access status: gold
Estimated APC paid: $3,499
Award: 中药辛/苦味活血化瘀功效的化学和生物学基础研究
OpenAlex ID: W2483736282
